Skip to main content
. 2014 Mar 15;7(4):1348–1358.

Table 2.

Association of SERPINA3 expression level with clinical parameters

Variable Expression Level of SERPINA3 Cases Χ2-value P-value

High Low
Tissue Group Normal 12 48 60 15.137 <.0001
Cancer 77 80 157
Stage I 30 64 94 37.291 <.0001
II 14 13 27
III-IV 33 3 36
Histology Type G1 13 33 46 22.434 <.0001
G2 27 35 62
G3+UPSC+CC 37 12 49
Menopause Y 60 57 117 0.920 0.337
N 17 23 40
Estrogen Receptor α (ERα) (+) 38 61 99 12.187 <.0001
(-) 39 19 58
Progesterone Receptor (PR) (+) 57 67 124 2.235 0.135
(-) 20 13 33
Depth of Myometrial Invasion ≤50% 38 48 86 1.796 0.180
>50% 39 32 71
Lymph node status (+) 16 0 16 <.0001#
(-) 61 80 141
Vascular thrombosis (+) 55 77 126 7.429 0.006
(-) 22 9 31
#

Fisher’s exact test; χ2 tests were applied for all other analysis.